Artal Group’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-504,978
| Closed | -$7.75M | – | 107 |
|
|
2023
Q3 | $7.75M | Hold |
504,978
| – | – | 0.33% | 49 |
|
|
2023
Q2 | $12M | Hold |
504,978
| – | – | 0.37% | 40 |
|
|
2023
Q1 | $12.8M | Buy |
+504,978
| New | +$12.8M | 0.76% | 33 |
|
|
2019
Q2 | – | Sell |
-33,333
| Closed | -$1.4M | – | 109 |
|
|
2019
Q1 | $1.4M | Hold |
33,333
| – | – | 0.06% | 84 |
|
|
2018
Q4 | $1.52M | Hold |
33,333
| – | – | 0.06% | 73 |
|
|
2018
Q3 | $2.79M | Hold |
33,333
| – | – | 0.07% | 71 |
|
|
2018
Q2 | $3.21M | Hold |
33,333
| – | – | 0.07% | 60 |
|
|
2018
Q1 | $3.51M | Buy |
33,333
+26,666
| +400% | +$2.8M | 0.04% | 57 |
|
|
2017
Q4 | $1.04M | Hold |
6,667
| – | – | 0.02% | 75 |
|
|
2017
Q3 | $915K | Buy |
+6,667
| New | +$915K | 0.02% | 78 |
|